These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24662107)

  • 1. Severe cutaneous adverse reactions to drugs: from patients to the national office for compensation of medical accidents.
    Isvy-Joubert A; Ingen-Housz-Oro S; Vincent R; Haddad C; Valeyrie-Allanore L; Chosidow O; Race JM; Wolkenstein P
    Dermatology; 2014; 228(4):338-43. PubMed ID: 24662107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of serious adverse drug reactions: proposals from a victims' organisation.
    Prescrire Int; 2012 Sep; 21(130):220-3. PubMed ID: 23016261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General characteristics, economic burden, causative drugs and medical errors associated with medical damage litigation involving severe cutaneous adverse drug reactions in China.
    Zheng ZQ; Jiang C; Yu RL; Zhou JQ; Wu ZJ; Luo JY
    J Clin Pharm Ther; 2020 Oct; 45(5):1087-1097. PubMed ID: 32516456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
    Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
    Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
    Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.
    Arantes LB; Reis CS; Novaes AG; Carvalho MR; Göttems LBD; Novaes MRCG
    An Bras Dermatol; 2017; 92(5):661-667. PubMed ID: 29166503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compensation for medical accidents resulting from the delivery of health care].
    Cardona J; Cordier AL; Malicier D
    Rev Prat; 2005 May; 55(10):1057-9. PubMed ID: 16097245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regional commission for medical accidents and nosocomial infections set up by French law.
    Bartoli C; Piercecchi-Marti MD; Pelissier-Alicot AL; Cianfarani F; Leonetti G
    Med Sci Law; 2005 Jul; 45(3):211-8. PubMed ID: 16117281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study.
    Guzman AK; Zhang M; Kwatra SG; Kaffenberger BH
    J Am Acad Dermatol; 2020 Feb; 82(2):303-310. PubMed ID: 31542405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
    Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
    Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
    Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
    Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical accountability: current elements].
    Bergoignan-Esper C
    Bull Acad Natl Med; 2014; 198(4-5):689-700; discussion 700-1. PubMed ID: 26753401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Litigations following spinal neurosurgery in France: "out-of-court system," therapeutic hazard, and welfare state.
    Debono B; Gerson C; Houselstein T; Lettat-Ouatah L; Bougeard R; Lonjon N
    Neurosurg Focus; 2020 Nov; 49(5):E11. PubMed ID: 33130623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inequity of compensation trajectories for victims of medical injuries. A survey in the French out-of-court settlement mechanism].
    Parizot I; Cailbault I; Winance M; Barbot J
    Rev Epidemiol Sante Publique; 2017 Apr; 65(2):99-108. PubMed ID: 28236496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
    Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
    JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and mortality from epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis) in France during 2003-16: a four-source capture-recapture estimate.
    Chaby G; Maldini C; Haddad C; Lebrun-Vignes B; Hemery F; Ingen-Housz-Oro S; Gonzalez-Chiappe S; Wolkenstein P; Chosidow O; Mahr A; Fardet L
    Br J Dermatol; 2020 Mar; 182(3):618-624. PubMed ID: 31396952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.